| Device |
reagents, zika virus nucleic acid |
| Definition |
Nucleic acid-based in vitro diagnostic devices for the detection of Zika virus and diagnosis of Zika virus infection in human clinical specimens. |
| Physical State |
In Vitro Diagnostic Primers, Probes and/or capture oligonucleotides. |
| Technical Method |
Nucleic acid amplification. |
| Target Area |
The device is an in-vitro diagnostic device; none of the body parts will utilize the device or are intended to be affected by the device. |
| Review Panel |
Microbiology |
| Product Code | POA |
| Premarket Review |
Division of Microbiology Devices
(DMD)
Division of Microbiology Devices
(DMD)
|
|
Not Classified Reason
|
EUA - Emergency Use Authorization
|
| Submission Type |
EUA - Emergency Use Authorization
|
| Device Class |
Not Classified
|
| Total Product Life Cycle (TPLC) |
TPLC Product Code Report
|
| GMP Exempt? |
No
|
Summary Malfunction Reporting |
Ineligible |
| Implanted Device? |
No
|
| Life-Sustain/Support Device? |
No
|
| Third Party Review |
Not Third Party Eligible |